Details der Publikation - Out-of-pocket costs sustained in the last 12 months by cancer patients

Out-of-pocket costs sustained in the last 12 months by cancer patients : an Italian survey-based study on individual expenses between 2017 and 2018 / Roberto Lillini, Francesco De Lorenzo, Paolo Baili, Elisabetta Iannelli, Laura M. Del Campo, Dina Pero, Gianfranca Traclò, Alessandro Sproviero, Milena Sant, Francesco Perrone

Medienart:	E-Artikel

Erscheinungsjahr:	2023
Erschienen:	2023

Enthalten in:	Zur Gesamtaufnahme - volume:24
Enthalten in:	The European journal of health economics - 24(2023), 8 vom: Nov., Seite 1309-1319

Sprache:	Englisch

Beteiligte Personen:	Lillini, Roberto [VerfasserIn] De Lorenzo, Francesco [VerfasserIn] Baili, Paolo [VerfasserIn] Iannelli, Elisabetta [VerfasserIn] Del Campo, Laura M. [VerfasserIn] Pero, Dina [VerfasserIn] Traclò, Gianfranca [VerfasserIn] Sproviero, Alessandro [VerfasserIn] Sant, Milena [VerfasserIn] Perrone, Francesco [VerfasserIn]

Links:	link.springer.com [lizenzpflichtig] doi.org [lizenzpflichtig]

Themen:	Cancer care Cancer patients Financial toxicity National health system Out-of-pocket health expenditures

doi:	10.1007/s10198-022-01544-9

funding:
Förderinstitution / Projekttitel:

PPN (Katalog-ID):	1870633075

Internformat


LEADER	01000naa a2200265 4500
001	1870633075
003	DE-627
005	20231120090558.0
007	cr uuu---uuuuu
008	231120s2023 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.1007/s10198-022-01544-9 \|2 doi
035			\|a (DE-627)1870633075
035			\|a (DE-599)KXP1870633075
040			\|a DE-627 \|b ger \|c DE-627 \|e rda
041			\|a eng
100	1		\|a Lillini, Roberto \|e verfasserin \|4 aut
245	1	0	\|a Out-of-pocket costs sustained in the last 12 months by cancer patients \|b an Italian survey-based study on individual expenses between 2017 and 2018 \|c Roberto Lillini, Francesco De Lorenzo, Paolo Baili, Elisabetta Iannelli, Laura M. Del Campo, Dina Pero, Gianfranca Traclò, Alessandro Sproviero, Milena Sant, Francesco Perrone
264		1	\|c 2023
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
650		4	\|a Cancer care \|7 (dpeaa)DE-206
650		4	\|a Cancer patients \|7 (dpeaa)DE-206
650		4	\|a Financial toxicity \|7 (dpeaa)DE-206
650		4	\|a National health system \|7 (dpeaa)DE-206
650		4	\|a Out-of-pocket health expenditures \|7 (dpeaa)DE-206
700	1		\|a De Lorenzo, Francesco \|e verfasserin \|4 aut
700	1		\|a Baili, Paolo \|e verfasserin \|4 aut
700	1		\|a Iannelli, Elisabetta \|e verfasserin \|4 aut
700	1		\|a Del Campo, Laura M. \|e verfasserin \|4 aut
700	1		\|a Pero, Dina \|e verfasserin \|4 aut
700	1		\|a Traclò, Gianfranca \|e verfasserin \|4 aut
700	1		\|a Sproviero, Alessandro \|e verfasserin \|4 aut
700	1		\|a Sant, Milena \|e verfasserin \|4 aut
700	1		\|a Perrone, Francesco \|e verfasserin \|4 aut
773	0	8	\|i Enthalten in \|t The European journal of health economics \|d Berlin : Springer, 2001 \|g 24(2023), 8 vom: Nov., Seite 1309-1319 \|h Online-Ressource \|w (DE-627)320494462 \|w (DE-600)2011428-X \|w (DE-576)09670425X \|x 1618-7601 \|7 nnns
773	1	8	\|g volume:24 \|g year:2023 \|g number:8 \|g month:11 \|g pages:1309-1319
856	4	0	\|u https://link.springer.com/content/pdf/10.1007/s10198-022-01544-9.pdf \|x Verlag \|z lizenzpflichtig
856	4	0	\|u https://doi.org/10.1007/s10198-022-01544-9 \|x Resolving-System \|z lizenzpflichtig
912			\|a GBV_USEFLAG_U
912			\|a GBV_ILN_26
912			\|a ISIL_DE-206
912			\|a SYSFLAG_1
912			\|a GBV_KXP
912			\|a GBV_ILN_11
912			\|a GBV_ILN_20
912			\|a GBV_ILN_22
912			\|a GBV_ILN_23
912			\|a GBV_ILN_24
912			\|a GBV_ILN_31
912			\|a GBV_ILN_32
912			\|a GBV_ILN_39
912			\|a GBV_ILN_40
912			\|a GBV_ILN_60
912			\|a GBV_ILN_62
912			\|a GBV_ILN_63
912			\|a GBV_ILN_69
912			\|a GBV_ILN_70
912			\|a GBV_ILN_73
912			\|a GBV_ILN_74
912			\|a GBV_ILN_90
912			\|a GBV_ILN_95
912			\|a GBV_ILN_100
912			\|a GBV_ILN_101
912			\|a GBV_ILN_105
912			\|a GBV_ILN_110
912			\|a GBV_ILN_120
912			\|a GBV_ILN_138
912			\|a GBV_ILN_150
912			\|a GBV_ILN_151
912			\|a GBV_ILN_152
912			\|a GBV_ILN_161
912			\|a GBV_ILN_170
912			\|a GBV_ILN_171
912			\|a GBV_ILN_187
912			\|a GBV_ILN_213
912			\|a GBV_ILN_224
912			\|a GBV_ILN_230
912			\|a GBV_ILN_250
912			\|a GBV_ILN_267
912			\|a GBV_ILN_281
912			\|a GBV_ILN_285
912			\|a GBV_ILN_293
912			\|a GBV_ILN_370
912			\|a GBV_ILN_374
912			\|a GBV_ILN_602
912			\|a GBV_ILN_636
912			\|a GBV_ILN_702
912			\|a GBV_ILN_711
912			\|a GBV_ILN_2001
912			\|a GBV_ILN_2003
912			\|a GBV_ILN_2004
912			\|a GBV_ILN_2005
912			\|a GBV_ILN_2006
912			\|a GBV_ILN_2007
912			\|a GBV_ILN_2008
912			\|a GBV_ILN_2009
912			\|a GBV_ILN_2010
912			\|a GBV_ILN_2011
912			\|a GBV_ILN_2014
912			\|a GBV_ILN_2015
912			\|a GBV_ILN_2018
912			\|a GBV_ILN_2020
912			\|a GBV_ILN_2021
912			\|a GBV_ILN_2025
912			\|a GBV_ILN_2026
912			\|a GBV_ILN_2027
912			\|a GBV_ILN_2031
912			\|a GBV_ILN_2037
912			\|a GBV_ILN_2038
912			\|a GBV_ILN_2039
912			\|a GBV_ILN_2044
912			\|a GBV_ILN_2048
912			\|a GBV_ILN_2049
912			\|a GBV_ILN_2050
912			\|a GBV_ILN_2055
912			\|a GBV_ILN_2056
912			\|a GBV_ILN_2057
912			\|a GBV_ILN_2059
912			\|a GBV_ILN_2061
912			\|a GBV_ILN_2064
912			\|a GBV_ILN_2065
912			\|a GBV_ILN_2068
912			\|a GBV_ILN_2088
912			\|a GBV_ILN_2093
912			\|a GBV_ILN_2106
912			\|a GBV_ILN_2107
912			\|a GBV_ILN_2108
912			\|a GBV_ILN_2110
912			\|a GBV_ILN_2111
912			\|a GBV_ILN_2112
912			\|a GBV_ILN_2113
912			\|a GBV_ILN_2118
912			\|a GBV_ILN_2122
912			\|a GBV_ILN_2129
912			\|a GBV_ILN_2143
912			\|a GBV_ILN_2144
912			\|a GBV_ILN_2147
912			\|a GBV_ILN_2148
912			\|a GBV_ILN_2152
912			\|a GBV_ILN_2153
912			\|a GBV_ILN_2188
912			\|a GBV_ILN_2190
912			\|a GBV_ILN_2232
912			\|a GBV_ILN_2336
912			\|a GBV_ILN_2446
912			\|a GBV_ILN_2470
912			\|a GBV_ILN_2472
912			\|a GBV_ILN_2507
912			\|a GBV_ILN_2522
912			\|a GBV_ILN_2548
912			\|a GBV_ILN_2941
912			\|a GBV_ILN_2949
912			\|a GBV_ILN_2950
912			\|a GBV_ILN_4012
912			\|a GBV_ILN_4035
912			\|a GBV_ILN_4037
912			\|a GBV_ILN_4046
912			\|a GBV_ILN_4112
912			\|a GBV_ILN_4125
912			\|a GBV_ILN_4126
912			\|a GBV_ILN_4242
912			\|a GBV_ILN_4246
912			\|a GBV_ILN_4249
912			\|a GBV_ILN_4251
912			\|a GBV_ILN_4277
912			\|a GBV_ILN_4305
912			\|a GBV_ILN_4306
912			\|a GBV_ILN_4307
912			\|a GBV_ILN_4313
912			\|a GBV_ILN_4322
912			\|a GBV_ILN_4323
912			\|a GBV_ILN_4324
912			\|a GBV_ILN_4325
912			\|a GBV_ILN_4326
912			\|a GBV_ILN_4328
912			\|a GBV_ILN_4333
912			\|a GBV_ILN_4334
912			\|a GBV_ILN_4335
912			\|a GBV_ILN_4336
912			\|a GBV_ILN_4338
912			\|a GBV_ILN_4346
912			\|a GBV_ILN_4392
912			\|a GBV_ILN_4393
912			\|a GBV_ILN_4700
936	u	w	\|d 24 \|j 2023 \|e 8 \|c 11 \|h 1309-1319
951			\|a AR
952			\|d 24 \|j 2023 \|e 8 \|c 11 \|h 1309-1319
980			\|2 26 \|1 01 \|x 0206 \|b 4413898494 \|y x1z \|z 20-11-23
982			\|2 26 \|1 00 \|x DE-206 \|b Purpose Out of Pocket costs (OOP) sustained by cancer patients also in public NHS contribute to disease-related fnancial toxicity. Aim of the study was to investigate the amount and the types of OOP sustained by Italian cancer patients for care services. Methods A sample survey was conducted by FAVO in December 2017-June 2018, in 39 adhering hospitals and 1289 patients diagnosed from 1985 to 2018, by standardized questionnaire inquiring on: yearly expenditure by cancer service, age, year of diagnosis, disease phase, cancer site, sex, marital status, education, residence. Univariate and multivariable regression analyses were performed between OOP and each variable. Multilevel mixed-efects negative binomial regression was used to assess the combined efects of patients characteristics on the diferences in acquiring health services. Results The yearly average OOP was 1841.81€, with the highest values for transports (359.34€) and for diagnostic examinations (259.82€). Signifcantly higher OOP were found in North and Centre than South and Islands (167.51 vs. 138.39). In the fully adjusted multivariable analysis, the variables signifcantly associated with higher than reference expenditure were: medium/high education (OR 1.22 [1.05-1.42], upper gastrointestinal tract cancer (OR 1.37 [1.06-1.77]), disease phase of treatments for cancer progression or pain therapy (OR 1.59 [1.30-1.93]). Conclusion Italian cancer patients in 2018 sustained OOP quite similar to those measured in 2012 to supplement NHS services. The main component of the OOP costs were diagnostic examination and transportation. The NHS should pay attention to potentiate its ability to answer unmet needs of patients with advanced cancer who are the most fragile ones. Implications for cancer survivors Reinforcing the services where the main OOP expenses are located can help in promoting public health actions and reduce socio-economic needs that could compromise the receipt of optimal care along the whole disease course, from diagnosis to rehabilitation.

Zugang & Verfügbarkeit

Zugehörige Publikationen/Bände